RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Capecitabine Compared with Capecitabine Plus Oxaliplatin Chemoradiotherapy
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 31
SP 10
OP 11
DO 10.1177/155989771431006
UL http://mdc.sagepub.com/content/14/31/10.abstract
AB Preliminary findings demonstrate that patients with rectal cancer receiving radiotherapy with a combination of capecitabine and oxaliplatin have better local regional control compared with those receiving capecitabine plus radiotherapy. This article presents interim data from the ongoing phase 3 open-label Adjuvant Treatment of Concurrent R and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer trial [NCT00714077].